Product Information
METOCLOPRAMIDE 10 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0438 per EA under NDC 50228023301. Its NADAC has been published 54 times since Aug 13, 2025.
FDA first approved this application on Jan 30, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228023301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072215FDA Approved
1/30/1990
TE Code
AB
On Market Since
2/12/2025
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 10 MG TABLET has been published 54 times since Aug 13, 2025, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0438 per EA |
|---|---|
| All-time high | $0.0502 (Aug 13, 2025) |
| All-time low | $0.0438 (Aug 19, 2026) |
| 52-week high | $0.0502 |
| 52-week low | $0.0438 |
| Median price | $0.0487 |
| Average price | $0.0475 |
| Largest weekly change | -4.8% (Mar 18, 2026) |
| Weeks tracked | 54 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 10 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0438 per EA (NDC 50228023301), effective Aug 19, 2026.
How has the price of METOCLOPRAMIDE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 10 MG TABLET has declined 12.6%. It has been tracked across 54 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 10 MG TABLET?
Since Aug 13, 2025, the NADAC for METOCLOPRAMIDE 10 MG TABLET has ranged from a low of $0.0438 (Aug 19, 2026) to a high of $0.0502 (Aug 13, 2025), with a median of $0.0487 per EA.
Are there cheaper alternatives to METOCLOPRAMIDE 10 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 10 MG TABLET?
METOCLOPRAMIDE 10 MG TABLET (NDC 50228023301) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.